Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  OTC Bulletin Board - Other OTC  >  Angiogenex Inc    AGGX

ANGIOGENEX INC (AGGX)
Mes dernières consult.
Most popular
Report
 SummaryQuotesChartsNewsCompany 
Quotes 5-day view   Delayed Quote. Delayed Otc Bulletin Board - Othe…
11/09/2017 11/10/2017 11/29/2017 11/30/2017 11/29/2017 Date
0.3(c) 0.45(c) 0.28(c) 0(c) 0.28 Last
3 000 25 950 161 2 161 Volume
+6.38% +50.00% -37.78% -100.00% -37.78% Change
More quotes
Company
AngioGenex, Inc. is a biopharmaceutical company, which focuses on creating products for the treatment, diagnosis and prognosis of cancer.The company was founded by Michael M. Strage on March 31, 1999 and is headquartered in New York, NY. 
More about the company
Latest news on ANGIOGENEX INC
12/05 ANGIOGENEX INC : Michael Aronstein to Head AngioGenex, Inc. Board of Directors
12/05 ANGIOGENEX, INC. : Change in Directors or Principal Officers, Regulation FD Disc..
11/14 ANGIOGENEX : Management's Discussion and Analysis of Financial Condition and Res..
04/11 ANGIOGENEX, INC. : Financial Statements and Exhibits (form 8-K)
2008 ANGIOGENEX INC COM USD0.001 : AngioGenex Reviews 2008 Achievements and Sets Goal..
2008 ANGIOGENEX INC COM USD0.001 : AngioGenex Appoints New CEO to Direct Development ..
More news
Sector news : Biotechnology & Medical Research - NEC
09:44a M&A dominates Europe share trading; weak banks offset oil boost
12/09 Tax-loss selling to pressure 2017's losers in December
11/30 GENMAB : and J&J 'love' partnership as some ponder takeover
11/27 MERCK AND : As Brexit looms, UK pitches new industry plan, wins support from Mer..
11/27 MERCK AND : As Brexit looms, UK pitches new industry plan, wins support from Mer..
More sector news : Biotechnology & Medical Research - NEC
Chart ANGIOGENEX INC
Duration : Period :
Angiogenex Inc Technical Analysis Chart | AGGX | US03475U3014 | 4-Traders
Managers
NameTitle
Robert Benezra President, Chief Executive Officer & Director
Michael M. Strage Chairman, Chief Operating Officer & VP
Michael Charles Aronstein Non-Executive Chairman
Martin F. Murray Director & Chief Financial Officer
Sector and Competitors
1st jan.Capitalization (M$)
ANGIOGENEX INC16.67%0
CELLTRION, INC.--.--%22 034
IQVIA HOLDINGS INC32.81%21 333
INCYTE CORPORATION-6.46%20 382
LONZA GROUP54.74%19 270
ALNYLAM PHARMACEUTICALS, INC.239.21%12 871